Moore M A, Thamavit W, Tsuda H, Ito N
Cancer Lett. 1986 Feb;30(2):153-60. doi: 10.1016/0304-3835(86)90083-2.
The comparative modifying potential of dehydroepiandrosterone (DHEA), diaminopropane (DAP), phenobarbital (PB), butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the development of lesions initiated by dihydroxy-di-n-propyl nitrosamine (DHPN) in F344 rats were investigated. DHEA, BHA and BHT were all associated with significant reduction in numbers of glutathione-S-transferase P form (GST-P) positive foci in the liver whereas PB brought about their enhanced development. BHT and PB exerted promoting activity on the incidence of thyroid adenomas while DAP similarly increased lung adenoma formation. The results illustrate the advantages to be gained from two stage experiments using broad spectrum carcinogen initiation for comparative analysis of 'modifiers' of the neoplastic process and suggest that studies of enzyme alteration within putative preneoplastic lesions may be directly relevant to elucidation of mechanisms underlying such modification.
研究了脱氢表雄酮(DHEA)、二氨基丙烷(DAP)、苯巴比妥(PB)、丁基羟基茴香醚(BHA)和丁基羟基甲苯(BHT)对F344大鼠中二羟基二正丙基亚硝胺(DHPN)引发的病变发展的比较修饰潜力。DHEA、BHA和BHT均与肝脏中谷胱甘肽-S-转移酶P型(GST-P)阳性灶数量的显著减少有关,而PB则使其发展增强。BHT和PB对甲状腺腺瘤的发生率具有促进作用,而DAP同样增加了肺腺瘤的形成。结果表明,使用广谱致癌物启动进行两阶段实验以对肿瘤形成过程的“修饰剂”进行比较分析具有优势,并表明对假定的癌前病变内酶改变的研究可能与阐明这种修饰的潜在机制直接相关。